Condition: Ischemic Stroke · Sponsor: Capital Medical University
This is an investigator-initiated phase III clinical trial employing a randomized, double-blind, placebo-controlled design. The primary objective of this study is to investigate the efficacy and safety of an interleukin-6 inhibitor (tocilizumab) combined with endovascular therapy in patients with acute posterior circulation large-vessel occlusion stroke.
This description comes directly from the study's public registry record.
Xunming Ji · 01083198962 · jixm@ccmu.edu.cn
Chuanjie Wu · 01083199439 · wuchuanjie@ccmu.edu.cn
Always discuss trial participation with your own doctor first.
| Suzhou Municipal Hospital | Suzhou, Anhui, China | Recruiting |
| Anyang People's Hospital | Anyang, Henan, China | Recruiting |
| Nanyang Central Hospital | Nanyang, Henan, China | Recruiting |
| The First Affiliated Hospital of Henan Medical University | Xinxiang, Henan, China | Recruiting |
| People's Hospital of Xihua | Zhoukou, Henan, China | Recruiting |
| People's Hospital of Linyi | Linyi, Shandong, China | Recruiting |
| Zibo Central Hospital | Zibo, Shandong, China | Recruiting |
| Xianyang First People's Hospital | Xianyang, Shanxi, China | Recruiting |
| Yuncheng Central Hospital | Yuncheng, Shanxi, China | Recruiting |
| Lishui Central Hospital | Lishui, Zhejiang, China | Recruiting |
| Taizhou enze Hospital | Taizhou, Zhejiang, China | Recruiting |
| People's Hospital of Yueqing | Yueqing, Zhejiang, China | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07509645